PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

Reported: August 5, 2020 Initiated: July 17, 2020 #D-1413-2020

Product Description

Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08

Reason for Recall

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Details

Units Affected
11,688 bottles
Distribution
Product was distributed to OH and may have been further distributed throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 11,688 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
Which agency issued this recall?
This recall was issued by the FDA Drug on August 5, 2020. Severity: Moderate. Recall number: D-1413-2020.